查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1788207

全球无创冠状动脉影像市场

Non-invasive Coronary Imaging
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 274 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球无创冠状动脉成像市场规模将达到 5.306 亿美元

全球非侵入性冠状动脉影像市场规模预计在2024年为3.923亿美元，到2030年将达到5.306亿美元，在2024-2030年的分析期内，复合年增长率为5.2%。心臟超音波图是本报告分析的细分市场之一，预计其复合年增长率为3.5%，到分析期结束时市场规模将达到2.048亿美元。心臟电脑断层扫描（CT）在分析期间的复合年增长率预计为6.6%。

美国市场规模估计为 1.069 亿美元，中国市场预计复合年增长率为 7.9%

美国非侵入性冠状动脉影像市场规模预计在2024年达到1.069亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到1.04亿美元，在2024-2030年的分析期间内，复合年增长率为7.9%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为2.6%和5.0%。在欧洲，预计德国市场的复合年增长率为3.3%。

全球无创冠状动脉影像市场—主要趋势与驱动因素摘要

非侵入性冠状动脉影像将如何改变心血管诊断的模式？

非侵入性冠状动脉影像正在彻底改变心血管诊断的格局，为临床医生提供一种更安全、更快速、更准确的方法来评估冠状动脉疾病 (CAD)，而无需进行导管操作。传统冠动脉摄影术(CAI) 虽然有效，但它是侵入性的，并且给患者带来很大的风险，包括潜在的血管损伤、显影剂过敏反应以及术后恢復时间。相较之下，冠状动脉电脑断层扫描 (CCTA)、心臟磁振造影(CMR) 和正子断层扫描 (PET) 等非侵入性技术能够高解析度可视化冠状血管，同时降低手术风险。这些技术对于检测斑块堆积、评估狭窄和评估整体心臟功能至关重要。患者可受益于更短的检查时间、更少的不适感和更短的住院时间，而医生可以获得详细的解剖和功能数据，使他们能够做出更明智的治疗决策。此外，非侵入性影像工具已成为预防心臟病学的必备工具，因为它们能够在症状出现之前很久就发现亚临床动脉粥状硬化。功能性评估的整合，例如基于CT的血流储备分数（FFR-CT），也正在弥合解剖图像与生理学见解之间的差距，从而能够更准确地识别导致缺血的病变。心血管疾病仍然是全球最大的死亡原因，预计未来非侵入性影像在早期发现和疾病管理中的作用将进一步增强。

科技在提高诊断准确性和效率方面发挥什么作用？

影像技术的进步在提高非侵入性冠状动脉成像解决方案的可靠性和普及性方面发挥了核心作用。 CT扫描仪的进步——更快的扫描速度、更低的辐射剂量和更高的空间解析度——使得冠状动脉CT血管摄影成为评估疑似冠状动脉疾病患者的第一线工具。同时，心臟MRI正被广泛用于评估心肌灌注、心肌活力和纤维化，而无需患者暴露于电离辐射。人工智慧和机器学习与成像平台的整合进一步提高了诊断准确性，实现了基于大规模数据分析的自动化狭窄检测、斑块表征和风险分层。这些技术也简化了工作流程，使放射科医师和心臟科医师能够更快、更一致地解读扫描结果。双能量CT和光子计数CT是下一代影像创新技术，可增强组织对比度并减少先前阻碍冠状动脉可视化的伪影。此外，负荷心电图 (CMR) 和正子断层扫描 (PET) 等功能性影像技术如今能够高度准确地洞察心肌血流和灌注障碍，这对于确定是否需要重组至关重要。与电子健康记录(EHR) 和云端基础共用系统的互通性实现了无缝数据集成，甚至第二意见咨询。这些技术飞跃不仅提高了准确性，还重塑了诊断途径，使其更快捷、更方便患者、更个人化。

临床实务和病患偏好的变化是否推动了采用？

不断变化的临床实践以及不断变化的患者期望在非侵入性冠状动脉成像方式日益增长的需求中发挥关键作用。循环系统和全科医生越来越多地推荐非侵入性影像作为稳定性胸痛和风险评估的第一线诊断方法，尤其是越来越多的证据支持其临床有效性。美国心臟病学会和欧洲心臟病学会等知名组织发布的指南越来越倾向于非侵入性操作，因为事实证明，非侵入性操作可以减少不必要的侵入性操作及其相关併发症。从患者的角度来看，方便、减少焦虑以及对更快康復的渴望意味着患者比以往任何时候都更有可能选择非侵入性的门诊诊断。这对于老年患者和患有多种併发症的患者尤其重要，因为侵入性检测对他们来说风险更高。非侵入性选项在远端医疗和远距保健模式中也更具扩充性，从而可以将诊断服务扩展到农村和服务不足地区的患者。此外，糖尿病、肥胖症和高血压等生活方式相关风险因素的增多，推动了对更早、更频繁的心血管筛检的需求，尤其是在无症状高风险族群中。为了应对这一转变，医院和影像中心正在投资多重模式影像系统，并扩展循环系统服务线以应对门诊诊断。所有这些趋势都代表着医疗服务提供者策略和患者心态的重大转变，支持全球医疗系统长期采用非侵入性冠状动脉成像。

推动非侵入性冠状动脉影像市场快速成长的因素是什么？

非侵入性冠状动脉影像市场的成长受到多种因素的推动，包括技术创新、临床路径的演变以及医疗服务体系的转变。其中最重要的驱动因素之一是成像平台的进步，这些平台能够即时、详细地显示冠状动脉的解剖结构和功能，并避免了侵入性手术固有的风险。扫描器速度、影像解析度和后处理软体的不断改进显着扩展了这些成像方式的临床效用。在最终用户方面，医疗保健提供者越来越依赖非侵入性成像来有效地对患者进行分类，减少不必要的心导管检查，并提高整体护理品质。这种转变得到了最新临床指南的支持，这些指南承认非侵入性手术（尤其是CCTA和心臟MRI）的诊断和预后价值。消费行为也影响市场动态，越来越多的患者积极寻求更安全的诊断方案并参与预防性筛检计画。此外，人工智慧成像工具的出现正在提高生产力，降低诊断变异性，并使全科医生和非专科医生更容易获得高级解读。医院网路和诊断影像中心也正在采用这些技术，以优化资源利用率、缩短诊断时间并提高病患吞吐量。许多国家的报销结构正在逐步调整，以适应这些变化，使非侵入性影像对医疗保健提供者更具经济可行性。最后，在人口老化、久坐不动的生活方式和不良饮食习惯的推动下，已开发国家和开发中国家心血管疾病的盛行率都在上升，这推动了对精准早期诊断工具的强劲且持续的需求。这些因素共同推动了全球非侵入性冠状动脉成像市场的快速扩张。

部分

模态（超音波心臟检查、心臟电脑断层扫描、心臟磁振造影、放射性核种心臟影像）；最终使用者（医院最终使用者、诊断影像中心最终使用者、研究机构最终使用者）

受访公司范例

  • Abbott Laboratories
  • Arterys Inc.
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • Carestream Health, Inc.
  • Circle Cardiovascular Imaging Inc.
  • Esaote SpA
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • HeartFlow, Inc.
  • Hitachi Medical Corporation
  • Hologic, Inc.
  • NeoSoft LLC
  • Neusoft Corporation
  • Philips Healthcare
  • Pie Medical Imaging
  • Positron Corporation
  • Samsung Medison Co., Ltd.
  • Siemens Healthineers
  • Viatronix, Inc.

人工智慧集成

我们正在利用有效的专家内容和人工智慧工具来改变市场和竞争情报。

Global Industry Analysts 没有遵循查询 LLM 或特定产业SLM 的典型规范，而是建立了一个来自世界各地专家的精选内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP32371

Global Non-invasive Coronary Imaging Market to Reach US$530.6 Million by 2030

The global market for Non-invasive Coronary Imaging estimated at US$392.3 Million in the year 2024, is expected to reach US$530.6 Million by 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Echocardiography, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$204.8 Million by the end of the analysis period. Growth in the Cardiac Computed Tomography segment is estimated at 6.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$106.9 Million While China is Forecast to Grow at 7.9% CAGR

The Non-invasive Coronary Imaging market in the U.S. is estimated at US$106.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$104.0 Million by the year 2030 trailing a CAGR of 7.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 5.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Global Non-Invasive Coronary Imaging Market - Key Trends & Drivers Summarized

How Is Non-Invasive Coronary Imaging Changing the Game in Cardiovascular Diagnosis?

Non-invasive coronary imaging is revolutionizing the landscape of cardiovascular diagnostics, offering clinicians safer, faster, and highly accurate methods to assess coronary artery disease (CAD) without the need for catheter-based procedures. Traditional coronary angiography, while effective, involves significant patient risk due to its invasive nature, including potential vascular injury, allergic reactions to contrast agents, and post-procedure recovery time. In contrast, non-invasive techniques such as coronary computed tomography angiography (CCTA), cardiac magnetic resonance imaging (CMR), and positron emission tomography (PET) are enabling high-resolution visualization of coronary vessels with reduced procedural risk. These technologies have become pivotal in detecting plaque buildup, assessing stenosis, and evaluating overall heart function. Patients benefit significantly from quicker turnaround times, minimal discomfort, and reduced hospital stays, while physicians gain access to detailed anatomical and functional data that supports more informed treatment decisions. Additionally, the ability of non-invasive imaging tools to detect subclinical atherosclerosis-well before symptoms appear-has made them indispensable in preventive cardiology. The integration of functional assessment through methods like fractional flow reserve derived from CT (FFR-CT) is also bridging the gap between anatomical imaging and physiological insight, allowing more accurate identification of ischemia-causing lesions. As cardiovascular disease remains the leading cause of mortality globally, the role of non-invasive imaging in early detection and disease management is only expected to grow stronger.

What Role Does Technology Play in Elevating Diagnostic Accuracy and Efficiency?

Advancements in imaging technologies are central to the growing reliability and adoption of non-invasive coronary imaging solutions. The evolution of CT scanners-marked by faster acquisition speeds, reduced radiation exposure, and improved spatial resolution-has made coronary CT angiography a frontline tool for evaluating patients with suspected coronary artery disease. Simultaneously, cardiac MRI is becoming more widely used to assess myocardial perfusion, viability, and fibrosis without exposing patients to ionizing radiation. The integration of artificial intelligence and machine learning into imaging platforms is further amplifying diagnostic accuracy, allowing for automated detection of stenosis, plaque characterization, and risk stratification based on large-scale data analysis. These technologies also streamline workflow, enabling radiologists and cardiologists to interpret scans faster and with greater consistency. Dual-energy CT and photon-counting CT are the next generation of imaging innovations, providing enhanced tissue contrast and reducing artifacts that previously hindered coronary visualization. Moreover, functional imaging techniques such as stress CMR and PET scans now offer highly precise insights into myocardial blood flow and perfusion defects, which are critical for determining the need for revascularization procedures. Interoperability with electronic health records (EHRs) and cloud-based sharing systems allows for seamless data integration and second-opinion consultations across institutions. These technological leaps are not just improving accuracy-they're reshaping the diagnostic pathway to be faster, more patient-friendly, and highly personalized.

Are Shifting Clinical Practices and Patient Preferences Driving Adoption?

Changing clinical practices, along with evolving patient expectations, are playing a pivotal role in the increased demand for non-invasive coronary imaging modalities. Cardiologists and general practitioners are now more inclined to recommend non-invasive imaging as a first-line diagnostic option for stable chest pain and risk assessment, especially with the growing body of evidence supporting its clinical efficacy. Guidelines from prominent organizations such as the American College of Cardiology and the European Society of Cardiology increasingly favor non-invasive modalities due to their proven ability to reduce unnecessary invasive procedures and associated complications. From the patient's perspective, the preference for non-invasive, outpatient-based diagnostics is stronger than ever, driven by a desire for convenience, lower anxiety levels, and quicker recovery. This is particularly relevant in older populations and those with multiple comorbidities, where invasive testing poses higher risks. Non-invasive options are also more scalable in telemedicine and remote healthcare models, allowing diagnostic services to be extended to patients in rural and underserved areas. Furthermore, the rising prevalence of lifestyle-related risk factors such as diabetes, obesity, and hypertension is prompting earlier and more frequent cardiovascular screening, especially in asymptomatic high-risk groups. Hospitals and imaging centers are responding to these shifts by investing in multi-modality imaging suites and expanding cardiology service lines to accommodate outpatient diagnostics. All these trends point toward a significant shift in both provider strategy and patient mindset, reinforcing the long-term adoption of non-invasive coronary imaging across healthcare systems worldwide.

What’s Powering the Rapid Growth of the Non-Invasive Coronary Imaging Market?

The growth in the non-invasive coronary imaging market is driven by several factors spanning technological innovation, evolving clinical pathways, and shifts in healthcare delivery systems. One of the foremost drivers is the advancement of imaging platforms capable of delivering detailed, real-time visualization of coronary anatomy and function without the inherent risks of invasive procedures. Continuous improvements in scanner speed, image resolution, and post-processing software have significantly broadened the clinical utility of these modalities. On the end-user side, healthcare providers are increasingly relying on non-invasive imaging to triage patients efficiently, reduce unnecessary cardiac catheterizations, and improve overall care quality. This shift is supported by updated clinical guidelines that recognize the diagnostic and prognostic value of non-invasive techniques, particularly CCTA and cardiac MRI. Consumer behavior is also influencing market dynamics, with a growing number of patients actively seeking safer diagnostic options and participating in preventive health screening programs. Additionally, the emergence of AI-enabled imaging tools has enhanced productivity, reduced diagnostic variability, and made advanced interpretation more accessible to general practitioners and non-specialist providers. Hospital networks and imaging centers are also embracing these technologies to optimize resource utilization, shorten diagnostic timelines, and improve patient throughput. Reimbursement structures in many countries are gradually aligning with these shifts, making non-invasive imaging financially viable for providers. Finally, rising cardiovascular disease prevalence across both developed and developing nations-driven by aging populations, sedentary lifestyles, and poor dietary habits-is creating a robust and ongoing demand for accurate, early-stage diagnostic tools. Together, these factors are fueling the rapid global expansion of the non-invasive coronary imaging market.

SCOPE OF STUDY:

The report analyzes the Non-invasive Coronary Imaging market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Modality (Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging, Radionuclide Cardiac Imaging); End-Use (Hospitals End-Use, Diagnostic Imaging Centers End-Use, Research Institutes End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Abbott Laboratories
  • Arterys Inc.
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • Carestream Health, Inc.
  • Circle Cardiovascular Imaging Inc.
  • Esaote S.p.A.
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • HeartFlow, Inc.
  • Hitachi Medical Corporation
  • Hologic, Inc.
  • NeoSoft LLC
  • Neusoft Corporation
  • Philips Healthcare
  • Pie Medical Imaging
  • Positron Corporation
  • Samsung Medison Co., Ltd.
  • Siemens Healthineers
  • Viatronix, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Non-invasive Coronary Imaging - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Shift Toward Early Cardiovascular Risk Detection Throws the Spotlight on Non-Invasive Imaging Modalities
    • Increased Patient Preference for Radiation-Free and Painless Diagnostics Strengthens the Business Case for Non-Invasive Imaging
    • Surging Global Burden of Coronary Artery Disease Propels Growth Across Diagnostic Ecosystems
    • Integration of Functional Imaging and Anatomical Mapping Expands the Addressable Market Opportunity in Complex Cases
    • Widespread Adoption of AI-Enhanced Image Interpretation Drives Diagnostic Accuracy and Workflow Efficiency
    • Advancements in CT and MRI Technologies Accelerate Demand for High-Resolution Non-Invasive Cardiac Imaging
    • Rising Utilization in Preventive Health Programs Spurs Growth in Asymptomatic and At-Risk Populations
    • Emergence of Hybrid Imaging Platforms Strengthens Clinical Relevance and Adoption Across Hospital Systems
    • Growth in Outpatient Cardiology Services and Diagnostic Clinics Sustains Market Expansion
    • Remote Diagnostics and Teleradiology Integration Opens New Avenues in Underserved and Rural Markets
    • Increasing Emphasis on Patient Safety and Procedure Efficiency Spurs Transition from Invasive to Non-Invasive Modalities
    • Consumer Awareness and Digital Health Trends Generate Demand for Non-Invasive, Personalized Cardiac Assessments
    • Infrastructure Modernization and Cardiac Center Investments in Emerging Economies Fuel Market Penetration
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Non-invasive Coronary Imaging Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Non-invasive Coronary Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Non-invasive Coronary Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Echocardiography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Echocardiography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Echocardiography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Cardiac Computed Tomography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Cardiac Computed Tomography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Cardiac Computed Tomography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Cardiac Magnetic Resonance Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Cardiac Magnetic Resonance Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Cardiac Magnetic Resonance Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Radionuclide Cardiac Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Radionuclide Cardiac Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Radionuclide Cardiac Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Diagnostic Imaging Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Diagnostic Imaging Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Diagnostic Imaging Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • JAPAN
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • CHINA
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • EUROPE
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Non-invasive Coronary Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Non-invasive Coronary Imaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • FRANCE
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • GERMANY
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Non-invasive Coronary Imaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Non-invasive Coronary Imaging by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • INDIA
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Non-invasive Coronary Imaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Non-invasive Coronary Imaging by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Non-invasive Coronary Imaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Non-invasive Coronary Imaging by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • AFRICA
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030

IV. COMPETITION